Active 0 6 0 6 O
or 7 9 7 9 O
prior 10 15 10 15 O
documented 16 26 16 26 O
autoimmune 27 37 27 37 B-chronic_disease
disease 38 45 38 45 I-chronic_disease
in 46 48 46 48 O
the 49 52 49 52 O
last 53 57 53 57 B-upper_bound
2 58 59 58 59 I-upper_bound
years 60 65 60 65 I-upper_bound

Confirmed 0 9 66 75 O
positive 10 18 76 84 O
test 19 23 85 89 O
results 24 31 90 97 O
for 32 35 98 101 O
human 36 41 102 107 B-chronic_disease
immunodeficiency 42 58 108 124 I-chronic_disease
virus 59 64 125 130 I-chronic_disease
( 65 66 131 132 I-chronic_disease
HIV 66 69 132 135 I-chronic_disease
) 69 70 135 136 I-chronic_disease
, 70 71 136 137 O
or 72 74 138 140 O
participants 75 87 141 153 O
with 88 92 154 158 O
chronic 93 100 159 166 O
or 101 103 167 169 O
active 104 110 170 176 B-chronic_disease
hepatitis 111 120 177 186 I-chronic_disease
B 121 122 187 188 I-chronic_disease
or 123 125 189 191 I-chronic_disease
C. 126 128 192 194 I-chronic_disease
Participants 129 141 195 207 O
who 142 145 208 211 O
have 146 150 212 216 O
a 151 152 217 218 O
history 153 160 219 226 O
of 161 163 227 229 O
hepatitis 164 173 230 239 O
B 174 175 240 241 O
or 176 178 242 244 O
C 179 180 245 246 O
who 181 184 247 250 O
have 185 189 251 255 O
undetectable 190 202 256 268 O
HBV 203 206 269 272 O
DNA 207 210 273 276 O
or 211 213 277 279 O
HCV 214 217 280 283 O
RNA 218 221 284 287 O
after 222 227 288 293 O
anti 228 232 294 298 B-treatment
- 232 233 298 299 I-treatment
viral 233 238 299 304 I-treatment
therapy 239 246 305 312 I-treatment
may 247 250 313 316 O
be 251 253 317 319 O
enrolled 254 262 320 328 O

Current 0 7 329 336 O
or 8 10 337 339 O
prior 11 16 340 345 O
use 17 20 346 349 O
of 21 23 350 352 O
immunosuppressive 24 41 353 370 B-treatment
medication 42 52 371 381 I-treatment
within 53 59 382 388 O
14 60 62 389 391 B-upper_bound
days 63 67 392 396 I-upper_bound
prior 68 73 397 402 I-upper_bound
to 74 76 403 405 O
the 77 80 406 409 O
first 81 86 410 415 O
dose 87 91 416 420 O
( 92 93 421 422 O
with 93 97 422 426 O
certain 98 105 427 434 O
exceptions 106 116 435 445 O
) 116 117 445 446 O

Participants 0 12 447 459 O
with 13 17 460 464 O
childhood 18 27 465 474 O
atopy 28 33 475 480 B-chronic_disease
or 34 36 481 483 O
asthma 37 43 484 490 B-chronic_disease
, 43 44 490 491 O
vitiligo 45 53 492 500 B-chronic_disease
, 53 54 500 501 O
alopecia 55 63 502 510 B-chronic_disease
, 63 64 510 511 O
Hashimoto 65 74 512 521 B-chronic_disease
syndrome 75 83 522 530 I-chronic_disease
, 83 84 530 531 O
Grave 85 90 532 537 B-chronic_disease
's 90 92 537 539 I-chronic_disease
disease 93 100 540 547 I-chronic_disease
, 100 101 547 548 O
or 102 104 549 551 O
psoriasis 105 114 552 561 B-chronic_disease
not 115 118 562 565 O
requiring 119 128 566 575 O
systemic 129 137 576 584 B-treatment
treatment 138 147 585 594 I-treatment
( 148 149 595 596 O
within 149 155 596 602 O
the 156 159 603 606 O
past 160 164 607 611 B-upper_bound
2 165 166 612 613 I-upper_bound
years 167 172 614 619 I-upper_bound
) 172 173 619 620 O
are 174 177 621 624 O
not 178 181 625 628 O
excluded 182 190 629 637 O

Prior 0 5 638 643 O
grade 6 11 644 649 O
greater 12 19 650 657 O
than 20 24 658 662 O
or 25 27 663 665 O
equal 28 33 666 671 O
to 34 36 672 674 O
3 37 38 675 676 B-lower_bound
immune 39 45 677 683 O
- 45 46 683 684 O
mediated 46 54 684 692 O
neurotoxicity 55 68 693 706 O
or 69 71 707 709 O
pneumonitis 72 83 710 721 O
( 84 85 722 723 O
or 85 87 723 725 O
any 88 91 726 729 O
other 92 97 730 735 O
unresolved 98 108 736 746 O
or 109 111 747 749 O
symptomatic 112 123 750 761 O
adverse 124 131 762 769 O
event 132 137 770 775 O
in 138 140 776 778 O
the 141 144 779 782 O
last 145 149 783 787 O
3 150 151 788 789 B-upper_bound
months 152 158 790 796 I-upper_bound
) 158 159 796 797 O
while 160 165 798 803 O
receiving 166 175 804 813 O
immunotherapy 176 189 814 827 B-treatment

combination 0 11 828 839 O
therapy 12 19 840 847 O
cohorts 20 27 848 855 O
must 28 32 856 860 O
have 33 37 861 865 O
an 38 40 866 868 O
advanced 41 49 869 877 O
solid 50 55 878 883 B-cancer
tumor 56 61 884 889 I-cancer
where 62 67 890 895 O
the 68 71 896 899 O
use 72 75 900 903 O
of 76 78 904 906 O
nivolumab 79 88 907 916 B-treatment
is 89 91 917 919 O
standard 92 100 920 928 B-treatment
therapy 101 108 929 936 I-treatment

